Clinical Trials Sponsored by Laboratoires URGO

Total 2164 results

Laboratoires URGO

Unknown

Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM) (FREEDOM)

Venous Leg Ulcer
Laboratoires URGO

Unknown

Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects (FUSION)

Healthy Subjects

France
Laboratoires URGO

Unknown

Management of Infection Risk in Non-comparative Trial (MINT) (MINT)

Venous Leg Ulcer
Laboratoires URGO

Unknown

Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children

Attention Deficit Hyperactivity Disorder

France
Laboratoires URGO

Recruiting

Clinical Evaluation in Real Life of TLC-NOSF Dressings in the Local Treatment of Chronic Wounds (DFU and VLU) (STARTLIFE)

Diabetic Foot Ulcer | Venous Leg Ulcer | Real Life Study | TLC-NOSF Dressings | QoL Questionnaire

France
Laboratoires URGO

Recruiting

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

Wound Infection | Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Acute Wounds

France
Laboratoires URGO

Completed

Efficacy and Safety of URGOBD001 Compression System (FUTURE)

Venous Leg Ulcer

France
Laboratoires URGO

Unknown

Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

Leg Ulcers

France
Laboratoires URGO

Completed

Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.

Varicose Ulcer

France
Laboratoires URGO

Completed

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers (CASSIOPEE)

Ulcers, Leg

France
Laboratoires URGO

Unknown

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers (DISCOVERY)

Diabetic Foot Ulcer

Czechia, France, Italy, Poland, Spain, United Kingdom
Laboratoires URGO

Unknown

HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer (HEAL)

Wound
Laboratoires URGO

Unknown

Assessment of the Efficacy and Safety of a New Wound Dressing in the Local Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer(s)

France
Moses Murandu
University of Birmingham; Laboratoires URGO; University of Wolverhampton

Unknown

Use of White Granulated Sugar on Wounds

Infected Wounds

United Kingdom
Central Hospital, Nancy, France
Sanofi; GlaxoSmithKline; Zambon SpA; Laboratoires URGO; Pierre Fabre Medicament; Bi... and other collaborators

Unknown

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure (ALPHO)

Neuromuscular Blocking Agents Anaphylaxis

France
CEN Biotech
Urgo Research, Innovation & Development

Recruiting

Effectiveness of a Nasal Spray on Viral Respiratory Infections

COVID-19 | Common Cold | Acute Respiratory Tract Infection | Flu, Human

France
Bright Uro

Active, not recruiting

Modern Urodynamics System Efficacy (MUSE) Study

Urologic Diseases | Urodynamics

United States
Uro-1 Medical

Not yet recruiting

Evaluation of a Soft Tissue Biopsy System for Trans-rectal and Trans-perineal Biopsy of the Prostate

Prostate Disease
Uro-Research, LLC

Unknown

Tissue Bonding Cystostomy(TBC) (TBC)

Urinary Incontinence | Spinal Cord Injury (SCI) | Chronic Urinary Retention
Uro-1 Medical

Recruiting

Use of Repris Needle in Bladder Injection

Overactive Bladder Syndrome

United States
Uro-1 Medical

Recruiting

Assessment of VMCore Biopsy Versus Standard of Care Biopsy

Prostate Cancer

United States
Uro Medical Corporation

Recruiting

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology (PROTECT)

Urinary Incontinence, Urge

United States
Ihedioha, Ugo, M.D.

Completed

Psychological Preparation for Colorectal Surgery: Impact of Video Education

Colorectal Surgery | Use of Video Education

United Kingdom
Argo Sante
GenSight Biologics

Completed

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

Leber's Hereditary Optic Neuropathy (LHON)

France
Forest Laboratories
Mylan Laboratories

Terminated

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension

Hypertension

United States
Laboratoires Thea

Not yet recruiting

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Laboratoires Thea

Not yet recruiting

Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

Dry Eye Syndrome
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

United States, Colombia
Laboratoires Thea

Active, not recruiting

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension | Glaucoma

United States
Laboratoires Thea

Completed

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma
Laboratoires Vivacy

Completed

Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults

Aging | Skin Wrinkling

China
Laboratoires FILLMED

Completed

Evaluation of Anti-aging Performance and Tolerance of a Hyaluronic Acid-based Filler NCTF135HA® (HEBE2)

Aging

France
Laboratoires Thea

Completed

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma (CONDORE)

Glaucoma

France
Laboratoires Arkopharma

Completed

Management of Anxiety in Intensive Care Unit Including Olfactotherapy (OCEAN)

Anxiety

France
Laboratoires Teriak

Completed

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg (IDASCOP 1)

Diabetes Mellitus, Type 2 | Coronary Angioplasty | NSTEMI - Non-ST Segment Elevation MI

Tunisia
Laboratoires Genévrier

Completed

Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds (ECLAH)

Aesthetics

France
Laboratoires Genévrier

Completed

Evaluation of Efficacy and Safety of Ialuset Cream and Gauze in Second-degree Burns on Child

Second-degree Burn of Children

France
Laboratoires Thea

Completed

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. (T1030)

Glaucoma

France
Laboratoires Thea

Completed

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

France
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Glaucoma

France
Laboratoires Genévrier

Unknown

Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer (DERMAGEN®)

Diabetes | Foot Ulcer

France
Laboratoires NEGMA

Unknown

Study to Evaluate the Digestive Tolerability of ART44 Versus ART®50 in Patients With Osteoarthritis of the Knee

Knee Osteoarthritis
Laboratoires Thea

Completed

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Conjunctivitis, Bacterial
Laboratoires Thea

Completed

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial

France
Laboratoires Thea

Recruiting

Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome

Dry Eye

France
Laboratoires Vivacy

Recruiting

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal) (FaceHyal)

Aging | Aesthetics | Volume Deficiency in the Mid-Face

France
Laboratoires Thea

Completed

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

Dry Eye

Bulgaria
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

Estonia
Laboratoires Thea

Completed

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Healthy Volunteers

United States
Laboratoires Vivacy

Completed

Effectiveness and Safety of STYLAGE® M LIDOCAINE Versus STYLAGE® M in Filling Nasolabial Folds (MLIDOM)

Aging

France

3

Subscribe